Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Platelet function, hypertension and ischemic heart disease].

M Nyrop

    Ugeskrift for Laeger
    |September 25, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Endoscopic CO2 laser therapy of Zenker's diverticulum--experience from 61 patients.

    Acta oto-laryngologica. Supplementum·2000
    Same author

    Extensive cholesteatoma: long-term results of three surgical techniques.

    The Journal of laryngology and otology·1997
    Same author

    Kimura's disease: case report and brief review of the literature.

    The Journal of laryngology and otology·1994
    Same author

    Carcinoid tumor of the middle ear.

    Ear, nose, & throat journal·1994
    Same author

    [Cyclosporin A treatment of adult patients with severe nephrotic syndrome].

    Ugeskrift for laeger·1992
    Same author

    [Cardiovascular manifestations of hypothyroidism].

    Ugeskrift for laeger·1991

    Treating hypertension reduces cerebrovascular disease but not coronary heart disease (CHD). High blood pressure increases platelet aggregation, which normalizes with treatment, suggesting a role in CHD development.

    Area of Science:

    • Cardiovascular Medicine
    • Hematology
    • Vascular Biology

    Context:

    • Hypertension treatment impacts cardiovascular outcomes differently.
    • Arteriosclerosis, the basis of coronary heart disease (CHD), involves platelet activation.
    • Platelet activation can occur at damaged endothelium and via specific thrombocyte receptors.

    Purpose:

    • To investigate the relationship between mean arterial blood pressure (MAP), platelet aggregation, and coronary heart disease (CHD).
    • To explore the potential role of platelet aggregation in the development of CHD.

    Summary:

    • Mild to moderate hypertension treatment reduces cerebrovascular disease but not CHD frequency.
    • Patients with high MAP (>120 mmHg) exhibit increased platelet aggregation tendency, which normalizes upon blood pressure reduction.

    Related Experiment Videos

  • This hyper-aggregability appears linked to blood pressure, suggesting thrombocyte aggregation's significance in CHD development.

    • Impact:

    • Findings support the theory that platelet aggregation plays a role in coronary heart disease.
    • Understanding this link may inform future therapeutic strategies for CHD prevention.
    • Highlights the differential impact of hypertension treatment on various cardiovascular diseases.